Daiwa Securities Group
SBBP

Daiwa Securities Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

Daiwa Securities Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-220
Closed -$1K – 1266
2019
Q3 		$1K Hold
220
– – ﹤0.01% 1173
2019
Q2 		$1K Hold
220
– – ﹤0.01% 1197
2019
Q1 		$1K Buy
+220
New +$1.08K ﹤0.01% 1177
2018
Q4 		– Sell
-220
Closed -$1K – 1209
2018
Q3 		$1K Hold
220
– – ﹤0.01% 1156
2018
Q2 		$1K Hold
220
– – ﹤0.01% 1176
2018
Q1 		$2K Buy
+220
New +$1.65K ﹤0.01% 1138

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Daiwa Securities Group's SBBP Position: Q4 2019 in Review

Daiwa Securities Group sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2019, closing a stake of 220 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in SBBP in Q1 2018 and held it in 6 quarters. The position peaked at $2K in Q1 2018. 58 funds tracked by Wall St. Rank hold SBBP as of Q4 2019.

  • Daiwa Securities Group reported no remaining Strongbridge Biopharma plc. position as of Q4 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 220 Strongbridge Biopharma plc. shares in Q4 2019, an estimated $1K.
  • Daiwa Securities Group first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 6 quarters.
  • Daiwa Securities Group's Strongbridge Biopharma plc. position peaked at $2K in Q1 2018.
  • 58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2019.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.